PR Newswire Asia's news

 < Previous page   |   Title only   |   Print    Next page > 
     
Ping An Recognized as the World's Most Valuable Insurance Brand in "2026 Top 100 Most Valuable Global Brands" by Kantar BrandZ
HONG KONG and SHANGHAI , May 15, 2026 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or "the Group"; HKEX: 2318/82318; SSE: 601318) retained its ...
2026-05-15T    Banking/Financial Service   Insurance 
Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
KUALA LUMPUR, Malaysia , May 15, 2026 /PRNewswire/ -- Hong Leong Bank ("HLB" or the "Bank") has been named the Best Managed Bank in Malaysia at The Asian Banker ("TAB") ...
2026-05-15T    Banking/Financial Service 
Global South Media and Think Tank Forum Chinese-Arab Partnership Conference Opens in Cairo
Sinopec's Zhong Ren Delivers Keynote Speech and Receives Global South Outstanding Contribution Award ...
2026-05-15T    Chemical   Oil/Energy   Publishing/Information Service 
Changzhou's First Customer-Side "Smart Power Bank" Connected to Grid
CHANGZHOU, China , May 15, 2026 /PRNewswire/ -- On May 14, Changzhou's first customer-side grid-forming energy storage project was successfully connected to the grid at Qishuyan Rail Transit Industrial ...
2026-05-15T  
Bonree ONE 4.0 AI Capability System Upgraded, Advancing Observability Toward Intelligent Decision-Making
KUALA LUMPUR, Malaysia and BEIJING , May 15, 2026 /PRNewswire/ -- On 12 May 2026, during the Digital Cloud & Datacenter Convention & Exhibition (DCCI) Malaysia 2026, one of Southeast Asia's ...
2026-05-15T    Computer Software   Computer/Electronics   Internet Technology 
Gaotu Techedu to Report First Quarter 2026 Financial Results on June 2, 2026
BEIJING , May 15, 2026 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a leading technology-driven education company in China focused on enabling lifelong ...
2026-05-15T    Computer/Electronics   Education 
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
HONG KONG , May 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled ...
2026-05-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SWJTU lays tracks for unified rail future
University collaborates with ASEAN to harmonize cross-border train systems ...
2026-05-15T    Education   Higher Education   Publishing/Information Service 
NAVEE MENA 2026 Istanbul Partner Summit: Advancing an Integrated Land-Water-Sky Mobility Ecosystem
ISTANBUL , May 15, 2026 /PRNewswire/ -- NAVEE, a global leader in smart mobility innovation, hosted its inaugural NAVEE MENA 2026 Istanbul Partner Summit , marking a strategic leap into the Middle East. ...
2026-05-15T    Auto   Computer/Electronics   Retail   Transportation 
NTT Com Asia's OCEAN Intelligenceā„¢ Recognized with IFMA Asia Pacific Award of Excellence for Pioneering AI-Driven Facility Management
Transforming Building Management with AI to Empower Enterprises and Partners with a Definitive Technology Edge ...
2026-05-15T    Computer/Electronics   Internet Technology   Telecommunications 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.